ABD - İngilizce - NLM (National Library of Medicine)

covetrus - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - horse:  flunixin meglumine injectable solution is recommended for the alleviation of inflammation and pain associated with muscoskeletall disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: flunixin meglumine injectable solution is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. flunixin meglumine injectable solution is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of stillbirth. do not use flunixin meglumine injectable solution within 48 hours of expected parturition. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration are suspected. safety horse: a 3-fold intramuscular dose of 1.5 mg/lb of body weight daily for 10 consecutive days was safe. no changes were observed in hematology, serum chemistry, or urinalysis values. intravenous dosages of 0.5 mg/lb daily for 15 days; 1.5 mg/lb daily for 10 days; and 2.5 mg/lb daily for 5 days produced no changes in blood or urine parameters. no injection site irritation was observed following intramuscular injection of the 0.5 mg/lb recommended dose. some irritation was observed following a 3-fold dose administered intramuscularly. cattle: no flunixin-related changes (adverse reactions) were noted in cattle administered a 1x (2.2 mg/kg; 1.0 mg/lb) dose for 9 days (three times the maximum clinical duration). minimal toxicity manifested itself at moderately elevated doses (3x and 5x) when flunixin was administered daily for 9 days, with occasional findings of blood in the feces and/or urine. discontinue use if hematuria or fecal blood are observed.

ABD - İngilizce - NLM (National Library of Medicine)

henry schein animal health - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - indications horse: flunixiject™ injectable solution is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: flunixiject™ injectable solution is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. flunixiject™ injectable solution is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of

ABD - İngilizce - NLM (National Library of Medicine)

agri laboratories, ltd - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400), phenol (unii: 339ncg44tv) (phenol - unii:339ncg44tv) - flunixin meglumine 50 mg in 1 ml - horse :  flu-nix is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse.  it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle :  flu-nix is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis.   flu-nix is also indicated for the control of inflammation in endotoxemia. horse : there are no known contraindications to this drug when used as directed.  intra-arterial injection should be avoided.  horses inadvertently injected intra-arterial can show adverse reactions.  signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness.  signs are transient and disappear without antidotal medication within a few minutes.  do not use in horses showing hypersensitivity to flunixin meglumine. cattle :  there are no known contraindications to this drug in cattle when used as directed.  do not use in animals showing hypersensi

ABD - İngilizce - NLM (National Library of Medicine)

ax pharmaceutical corp - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin meglumine - unii:8y3jk0jw3u) - flunixin meglumine 495 g in 500 g

ABD - İngilizce - NLM (National Library of Medicine)

ax pharmaceutical corp - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin meglumine - unii:8y3jk0jw3u) - flunixin meglumine 24750 g in 25000 g

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

neove pharma australia pty limited - flunixin meglumine - unknown - flunixin meglumine benzene active 0.0 - active constituent

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

mavlab pty. ltd. - flunixin meglumine - unknown - flunixin meglumine benzene active 0.0 - active constituent

ABD - İngilizce - NLM (National Library of Medicine)

merck sharp & dohme corp. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin 50 mg in 1 ml - indications: banamine transdermal pour-on is indicated for the control of pyrexia associated with bovine respiratory disease and acute bovine mastitis, and the control of pain associated with foot rot in beef cattle 2 months of age and older and dairy cattle. not for use in beef and dairy bulls intended for breeding over 1 year of age, replacement dairy heifers over 20 months of age, dry dairy cows, dairy calves, or veal calves. contraindications: nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of stillbirth. do not use banamine transdermal pour-on within 48 hours of expected parturition. do not use in animals showing hypersensitivity to flunixin meglumine.

Avustralya - İngilizce - APVMA (Australian Pesticides and Veterinary Medicines Authority)

neove pharma australia pty limited - flunixin meglumine - parenteral liquid/solution/suspension - flunixin meglumine benzene active 50.0 mg/ml - musculoskeletal system - cattle | dog | horse | pigs | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | castra - analgesic | anti-inflammatory agent | antiprostaglandin | antipyretic | bone soreness | bruising | bursitis | colic | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle relaxant | muscle soreness | osteoarthritis | platelet activity | rheumatism | sedative | spasmolytic | sprains | strains | tendon sprains | traumatic swelling

İrlanda - İngilizce - HPRA (Health Products Regulatory Authority)

norbrook laboratories (ireland) limited - flunixin meglumine - solution for injection - 50 milligram(s)/millilitre - flunixin